Durham, NC · Founded 2019 · Privately Held (backing)
Developer of ocular gene therapies designed to reverse or prevent blindness. Atsena Therapeutics is based in Durham, NC and was founded in 2019. It was valued at $340 million at its later-stage round in Apr 2025, the last priced event on record. It has raised $238 million across 4 recorded rounds; the latest was a $90 million later-stage round in Mar 2025.
PMV mark · valuation
$340.0M
Oct 2026
Priced at
its later-stage round
Apr 2025
Total raised
$237.7M
Last round
Later Stage VC
Mar 2025
Cap table — not yet on record
Atsena Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Atsena Therapeutics with a free account
·The complete investor list: 12 names
·Watch Atsena Therapeutics: the Monday email on marks, rounds and moves
Where does Atsena Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Atsena Therapeutics's 4 recorded funding rounds.
